Portfolio Holdings Detail for ISIN IE00BYXG2H39
| Stock Name / Fund | iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares IV Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300ZP07LMR36K1T02 |
| ETF Ticker | BTEC(USD) LSE |
| ETF Ticker | BTEK(GBP) LSE |
| ETF Ticker | 2B70(EUR) F |
| ETF Ticker | 2B70.DE(EUR) CXE |
| ETF Ticker | BTEC.LS(USD) CXE |
| ETF Ticker | BTEK.LS(GBP) CXE |
| ETF Ticker | BTEC.L(GBP) LSE |
| ETF Ticker | BTEK.L(GBP) LSE |
Holdings detail for KYTX
| Stock Name | Kyverna Therapeutics, Inc. Common Stock |
| Ticker | KYTX(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
Show aggregate KYTX holdings
News associated with KYTX
- Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives $15.60 Consensus PT from Brokerages
- Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that are covering the firm, MarketBeat reports. Six analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price objective […] - 2025-09-01 03:01:10
- Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives Consensus Rating of “Buy” from Analysts
- Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) has been given a consensus rating of “Buy” by the seven ratings firms that are covering the stock, MarketBeat.com reports. Six investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target […] - 2025-07-10 05:47:03
- Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives $18.50 Average Target Price from Analysts
- Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) has been assigned an average recommendation of “Buy” from the seven brokerages that are currently covering the company, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1 year […] - 2025-06-18 02:07:00
- Squarepoint Ops LLC Acquires Shares of 11,488 Kyverna Therapeutics, Inc. (NASDAQ:KYTX)
- Squarepoint Ops LLC acquired a new stake in Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 11,488 shares of the company’s stock, valued at approximately $43,000. A number of other institutional investors have also recently bought and sold shares of KYTX. Gilead Sciences Inc. bought […] - 2025-06-11 04:34:45
- Public Employees Retirement System of Ohio Makes New $125,000 Investment in Kyverna Therapeutics, Inc. (NASDAQ:KYTX)
- Public Employees Retirement System of Ohio bought a new stake in shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 33,434 shares of the company’s stock, valued at approximately $125,000. A number of […] - 2025-06-06 05:26:48
- MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Position in Kyverna Therapeutics, Inc. (NASDAQ:KYTX)
- MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) by 53.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,288 shares of the company’s stock after buying an additional 4,990 shares during the […] - 2025-06-03 05:06:58
- Kyverna Therapeutics (NASDAQ:KYTX) Upgraded to Buy at HC Wainwright
- Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) was upgraded by investment analysts at HC Wainwright from a “neutral” rating to a “buy” rating in a research note issued on Tuesday, Marketbeat.com reports. The firm currently has a $5.00 price target on the stock, up from their previous price target of $4.00. HC Wainwright’s price objective […] - 2025-05-29 02:15:05
- Kyverna Therapeutics (NASDAQ:KYTX) versus Fresh Tracks Therapeutics (NASDAQ:FRTX) Head-To-Head Contrast
- Fresh Tracks Therapeutics (NASDAQ:FRTX – Get Free Report) and Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, profitability, valuation and risk. Insider and Institutional Ownership 25.0% of […] - 2025-05-20 02:39:00
- Cubist Systematic Strategies LLC Cuts Holdings in Kyverna Therapeutics, Inc. (NASDAQ:KYTX)
- Cubist Systematic Strategies LLC lessened its stake in Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) by 24.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 52,361 shares of the company’s stock after selling 16,597 shares during the period. […] - 2025-05-19 04:58:57
- Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Shares Sold by Price T Rowe Associates Inc. MD
- Price T Rowe Associates Inc. MD reduced its position in shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) by 5.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 593,688 shares of the company’s stock after selling 34,534 shares during the period. Price […] - 2025-05-08 05:06:52
- XTX Topco Ltd Lowers Holdings in Kyverna Therapeutics, Inc. (NASDAQ:KYTX)
- XTX Topco Ltd cut its position in shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) by 16.8% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 43,949 shares of the company’s stock after selling 8,843 shares during the period. XTX Topco Ltd’s holdings in Kyverna Therapeutics were worth $164,000 at the end […] - 2025-04-29 05:24:52
- Brokerages Set Kyverna Therapeutics, Inc. (NASDAQ:KYTX) PT at $18.33
- Shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) have been assigned an average recommendation of “Buy” from the seven brokerages that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating, five have assigned a buy rating and one has given a strong […] - 2025-04-29 02:20:49
- Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Shares Sold by JPMorgan Chase & Co.
- JPMorgan Chase & Co. reduced its position in Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) by 9.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,166,437 shares of the company’s stock after selling 220,915 shares during the quarter. […] - 2025-04-16 04:31:04
- Franklin Resources Inc. Has $2.59 Million Position in Kyverna Therapeutics, Inc. (NASDAQ:KYTX)
- Franklin Resources Inc. decreased its position in shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) by 26.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 692,028 shares of the company’s stock after selling 244,933 shares during the quarter. Franklin Resources Inc.’s holdings […] - 2025-04-13 05:46:57
- Brokerages Set Kyverna Therapeutics, Inc. (NASDAQ:KYTX) PT at $18.40
- Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven research firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has issued a strong buy recommendation on […] - 2025-04-04 02:12:45
- Morgan Stanley Has Lowered Expectations for Kyverna Therapeutics (NASDAQ:KYTX) Stock Price
- Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) had its price target cut by investment analysts at Morgan Stanley from $40.00 to $20.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Kyverna Therapeutics Trading Up 8.6 % Shares of KYTX stock opened at $2.15 on Tuesday. […] - 2025-04-03 04:34:48
- 9,154 Shares in Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Purchased by China Universal Asset Management Co. Ltd.
- China Universal Asset Management Co. Ltd. acquired a new position in Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) during the 4th quarter, HoldingsChannel reports. The fund acquired 9,154 shares of the company’s stock, valued at approximately $34,000. Other institutional investors also recently bought and sold shares of the company. JPMorgan Chase & Co. lifted its […] - 2025-02-05 06:46:52
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) KYTX holdings
| Date | Number of KYTX Shares Held | Base Market Value of KYTX Shares | Local Market Value of KYTX Shares | Change in KYTX Shares Held | Change in KYTX Base Value | Current Price per KYTX Share Held | Previous Price per KYTX Share Held |
|---|
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of KYTX by Blackrock for IE00BYXG2H39
Show aggregate share trades of KYTX| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-10-06 | BUY | 213 | 5.890 | 5.930 | 5.926 | USD 1,262 | 3.13 |
| 2025-10-03 | BUY | 497 | 5.520 | 6.250 | 6.177 | USD 3,070 | 3.11 |
| 2025-10-02 | BUY | 71 | 6.080 | 6.178 | 6.168 | USD 438 | 3.10 |
| 2025-09-30 | BUY | 142 | 6.000 | 6.150 | 6.135 | USD 871 | 3.07 |
| 2025-09-26 | BUY | 142 | 6.100 | 6.400 | 6.370 | USD 905 | 3.03 |
| 2025-09-25 | BUY | 142 | 6.350 | 6.520 | 6.503 | USD 923 | 3.01 |
| 2025-09-24 | BUY | 1 | 6.440 | 7.187 | 7.112 | USD 7 | 3.00 |
| 2025-09-18 | BUY | 70 | 5.010 | 5.040 | 5.037 | USD 353 | 2.98 |
| 2025-09-17 | BUY | 213 | 4.370 | 4.440 | 4.433 | USD 944 | 2.98 |
| 2025-09-11 | SELL | -71 | 4.150 | 4.290 | 4.276 | USD -304 | 2.95  Loss of -94 on sale |
| 2025-09-10 | BUY | 142 | 4.020 | 4.100 | 4.092 | USD 581 | 2.95 |
| 2025-09-05 | SELL | -71 | 3.940 | 3.940 | 3.940 | USD -280 | 2.93 Loss of -72 on sale |
| 2025-08-29 | SELL | -213 | 3.710 | 4.040 | 4.007 | USD -853 | 2.91 Loss of -234 on sale |
| 2025-08-27 | BUY | 142 | 3.690 | 3.861 | 3.844 | USD 546 | 2.90 |
| 2025-08-26 | SELL | -71 | 3.780 | 3.830 | 3.825 | USD -272 | 2.90 Loss of -66 on sale |
| 2025-08-25 | BUY | 71 | 3.810 | 4.000 | 3.981 | USD 283 | 2.89 |
| 2025-08-20 | SELL | -284 | 3.430 | 3.744 | 3.713 | USD -1,054 | 2.88 Loss of -236 on sale |
| 2025-08-18 | BUY | 142 | 3.540 | 3.870 | 3.837 | USD 545 | 2.87 |
| 2025-08-08 | SELL | -142 | 3.240 | 3.430 | 3.411 | USD -484 | 2.86 Loss of -78 on sale |
| 2025-08-05 | BUY | 71 | 3.410 | 3.490 | 3.482 | USD 247 | 2.85 |
| 2025-08-01 | SELL | -210 | 3.440 | 3.560 | 3.548 | USD -745 | 2.84 Loss of -148 on sale |
| 2025-07-30 | BUY | 280 | 3.760 | 4.029 | 4.002 | USD 1,121 | 2.83 |
| 2025-07-17 | SELL | -142 | 4.070 | 4.095 | 4.092 | USD -581 | 2.75 Loss of -191 on sale |
| 2025-07-11 | SELL | -568 | 4.030 | 4.060 | 4.057 | USD -2,304 | 2.71 Loss of -767 on sale |
| 2025-07-07 | BUY | 213 | 2.550 | 2.850 | 2.820 | USD 601 | 2.70 |
| 2025-07-02 | BUY | 3,850 | 2.825 | 2.975 | 2.960 | USD 11,396 | 2.69 |
| 2025-06-25 | BUY | 140 | 3.070 | 3.305 | 3.282 | USD 459 | 2.68 |
| 2025-06-11 | BUY | 140 | 3.310 | 3.820 | 3.769 | USD 528 | 2.63 |
| 2025-06-10 | BUY | 140 | 3.600 | 3.820 | 3.798 | USD 532 | 2.63 |
| 2025-06-04 | SELL | -70 | 2.850 | 2.885 | 2.881 | USD -202 | 2.61 Loss of -19 on sale |
| 2025-04-23 | BUY | 70 | 2.130 | 2.230 | 2.220 | USD 155 | 2.74 |
| 2025-04-10 | SELL | -560 | 1.870 | 1.940 | 1.933 | USD -1,082 | 2.84  Profit of 508 on sale |
| 2025-04-08 | SELL | -70 | 1.870 | 2.020 | 2.005 | USD -140 | 2.87 Profit of 61 on sale |
| 2025-04-07 | SELL | -70 | 1.910 | 2.075 | 2.059 | USD -144 | 2.89 Profit of 58 on sale |
| 2025-04-04 | SELL | -350 | 1.980 | 2.000 | 1.998 | USD -699 | 2.90 Profit of 316 on sale |
| 2025-04-01 | BUY | 280 | 1.980 | 2.080 | 2.070 | USD 580 | 2.93 |
| 2025-03-31 | SELL | -210 | 1.930 | 2.030 | 2.020 | USD -424 | 2.94 Profit of 194 on sale |
| 2025-03-14 | SELL | -1,120 | 2.500 | 2.650 | 2.635 | USD -2,951 | 3.08 Profit of 496 on sale |
| 2025-03-07 | SELL | -142 | 2.600 | 2.680 | 2.672 | USD -379 | 3.14 Profit of 66 on sale |
| 2025-03-04 | SELL | -71 | 2.630 | 2.710 | 2.702 | USD -192 | 3.18 Profit of 34 on sale |
| 2025-02-25 | BUY | 142 | 2.900 | 2.920 | 2.918 | USD 414 | 3.23 |
| 2025-02-19 | SELL | -71 | 2.890 | 3.060 | 3.043 | USD -216 | 3.28 Profit of 17 on sale |
| 2025-02-13 | BUY | 210 | 3.040 | 3.180 | 3.166 | USD 665 | 3.32 |
| 2025-02-12 | BUY | 70 | 2.660 | 2.945 | 2.916 | USD 204 | 3.35 |
| 2025-02-11 | BUY | 280 | 2.930 | 3.070 | 3.056 | USD 856 | 3.36 |
| 2025-01-17 | BUY | 280 | 3.330 | 3.525 | 3.506 | USD 982 | 3.54 |
| 2025-01-16 | BUY | 280 | 3.430 | 3.467 | 3.463 | USD 970 | 3.55 |
| 2025-01-10 | SELL | -140 | 3.450 | 3.700 | 3.675 | USD -515 | 3.84 Profit of 23 on sale |
| 2025-01-08 | SELL | -280 | 3.800 | 4.090 | 4.061 | USD -1,137 | 3.92 Loss of -39 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of KYTX
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 350,990 | 1,588 | 802,984 | 43.7% |
| 2025-09-18 | 99,860 | 30 | 428,454 | 23.3% |
| 2025-09-17 | 82,750 | 4 | 270,156 | 30.6% |
| 2025-09-16 | 33,609 | 0 | 122,692 | 27.4% |
| 2025-09-15 | 56,286 | 0 | 143,947 | 39.1% |
| 2025-09-12 | 80,128 | 26,078 | 108,224 | 74.0% |
| 2025-09-11 | 56,227 | 10,857 | 147,048 | 38.2% |
| 2025-09-10 | 70,288 | 18,767 | 165,596 | 42.4% |
| 2025-09-09 | 62,342 | 33,121 | 164,349 | 37.9% |
| 2025-09-08 | 76,082 | 37,911 | 146,099 | 52.1% |
| 2025-09-05 | 43,358 | 13,990 | 88,988 | 48.7% |
| 2025-09-04 | 61,255 | 10,000 | 106,842 | 57.3% |
| 2025-09-03 | 74,406 | 16,108 | 115,339 | 64.5% |
| 2025-09-02 | 32,748 | 2,604 | 86,281 | 38.0% |
| 2025-08-29 | 75,517 | 20,671 | 147,735 | 51.1% |
| 2025-08-28 | 40,564 | 10,100 | 92,940 | 43.6% |
| 2025-08-27 | 58,734 | 8,641 | 125,861 | 46.7% |
| 2025-08-26 | 23,809 | 0 | 47,111 | 50.5% |
| 2025-08-25 | 49,245 | 7,788 | 75,687 | 65.1% |
| 2025-08-22 | 147,691 | 10,760 | 316,881 | 46.6% |
| 2025-08-21 | 46,167 | 0 | 129,076 | 35.8% |
| 2025-08-20 | 60,632 | 8,000 | 141,213 | 42.9% |
| 2025-08-19 | 46,903 | 700 | 112,120 | 41.8% |
| 2025-08-18 | 79,421 | 100 | 254,210 | 31.2% |
| 2025-08-15 | 36,396 | 0 | 157,691 | 23.1% |
| 2025-08-14 | 52,185 | 0 | 117,049 | 44.6% |
| 2025-08-13 | 69,703 | 761 | 308,385 | 22.6% |
| 2025-08-12 | 98,654 | 1,000 | 447,321 | 22.1% |
| 2025-08-11 | 64,549 | 0 | 145,252 | 44.4% |
| 2025-08-08 | 36,163 | 2 | 89,470 | 40.4% |
| 2025-08-07 | 80,405 | 0 | 177,193 | 45.4% |
| 2025-08-06 | 18,696 | 113 | 38,438 | 48.6% |
| 2025-08-05 | 58,687 | 0 | 102,903 | 57.0% |
| 2025-08-04 | 14,061 | 0 | 63,676 | 22.1% |
| 2025-08-01 | 17,680 | 50 | 56,968 | 31.0% |
| 2025-07-31 | 44,023 | 0 | 78,493 | 56.1% |
| 2025-07-30 | 22,552 | 1,274 | 77,533 | 29.1% |
| 2025-07-29 | 50,611 | 3,482 | 139,837 | 36.2% |
| 2025-07-28 | 52,849 | 1 | 124,011 | 42.6% |
| 2025-07-25 | 22,586 | 236 | 50,817 | 44.4% |
| 2025-07-24 | 47,447 | 0 | 86,444 | 54.9% |
| 2025-07-23 | 42,401 | 0 | 136,913 | 31.0% |
| 2025-07-22 | 19,956 | 192 | 48,094 | 41.5% |
| 2025-07-21 | 14,255 | 0 | 43,232 | 33.0% |
| 2025-07-18 | 14,143 | 0 | 80,316 | 17.6% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.
Copyright Market Footprint Ltd. Privacy Policy